At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Triple-masked Randomized Controlled Trial Measuring Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block
In Brief
A Phase 4 clinical trial evaluating Ropivacaine 0.75%, Ropivacaine 0.75% + 300 mcg Buprenorphine, and 2 other interventions for Anesthesia, Local. Completed, enrolled 160 participants across 1 site.
Detailed Summary
This is a prospective randomized controlled triple-masked study looking at the duration of nerve block analgesia when using the listed adjuvants (dexamethasone, buprenorphine and clonidine) plus ropivacaine versus plain ropivacaine alone.
Study Details
Timeline
Interventions
Only ropivacaine 0.75% is administered for this arm of the interscalene block
Ropivacaine 0.75% + 300 mcg Buprenorphine is administered for this arm of the interscalene block
Ropivacaine 0.75% + 75 mcg Clonidine is administered for this arm of the interscalene block
Ropivacaine 0.75% + 8 mg Dexamethasone is administered for this arm of the interscalene block